We failed to detect a significance of FOSL1 mRNA in the prediction of survival for basal-like patients, which may be partially explained by the upregulation or activation of FOSL1 or FRA1 at both transcriptional and post-transcriptional levels in the development and progression of basal-like breast cancer [15, 35]. This evidence concerns the gene FOSL1 and breast carcinoma.